KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,620,424 | -81.5% | 770,713 | -42.9% | 0.01% | -79.3% |
| Q1 2021 | $14,200,000 | -62.8% | 1,349,800 | -45.2% | 0.03% | -65.1% |
| Q4 2020 | $38,158,000 | -18.7% | 2,465,000 | -23.3% | 0.08% | -29.1% |
| Q3 2020 | $46,909,000 | -23.8% | 3,212,931 | -1.1% | 0.12% | -25.9% |
| Q2 2020 | $61,531,000 | -14.0% | 3,248,739 | -12.8% | 0.16% | -26.2% |
| Q1 2020 | $71,529,000 | -1.5% | 3,723,532 | -1.7% | 0.21% | +20.2% |
| Q4 2019 | $72,597,000 | +343.9% | 3,787,000 | +122.8% | 0.18% | +345.0% |
| Q3 2019 | $16,354,000 | – | 1,700,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |